Skip to main content

Restless Legs Syndrome and Painful Legs/Moving Toes

  • Chapter
  • First Online:
Movement Disorders Curricula

Abstract

Restless legs syndrome (RLS), which has been recently renamed Willis–Ekbom disease (WED), is a neurological disorder characterized by unpleasant sensations in the legs, with an urge to move. Symptoms mainly occur at rest in the evening or at night, and they are alleviated by moving the affected extremity. In the general population, a RLS prevalence of 5 % has been reported.

Concerning the pathophysiology of RLS, some possible primary factors as brain iron deficiency, central nervous system dopamine regulation, and genetics have been identified.

Recent guidelines indicated that pharmacological treatment should be limited to those patients who suffer from clinically relevant RLS, that is, when symptoms significantly impair the patient’s daytime functioning, quality of life, and sleep. In patients affected by chronic RLS, a nonergot dopamine agonist or an α-2-δ calcium channel ligand are indicated. In the clinical practice, a dopamine agonist is more appropriate in case of depression and overweight presence. In case of comorbidities, such as chronic pain, anxiety, or insomnia, the α-2-δ ligands should be considered. RLS symptoms that are present through large part of the day and night may favor the use of long-acting agents, such as the rotigotine patch or gabapentin enacarbil. In refractory RLS patients, oral prolonged release oxycodone–naloxone should be appropriate.

Painful legs and moving toes syndrome (PLMTS) is a rare and underdiagnosed disorder. The pathophysiology of PLMTS is unknown, but most reports suggest an association with a peripheral lesion. Treatment is often unsatisfactory, but botulinum toxin and pramipexole showed long-term beneficial effect.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 149.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CSF:

Cerebrospinal fluid

EMG:

Electromyography

ICSD-3:

International classification of sleep disorders, 3rd edition

PLMS:

Periodic limb movements in sleep

PLMTS:

Painful legs and moving toes syndrome

PLMW:

Periodic limb movements in wakefulness

RLS:

Restless legs syndrome

SIT:

Suggested Immobilization Test

WED:

Willis–Ekbom disease

References

  1. Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010;6:337–46.

    Article  PubMed  Google Scholar 

  2. Montplaisir J, Allen R, Walters A, Ferini-Strambi L. Restless legs syndrome and periodic limb movements during sleep. In: Kryger H, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 4th ed. Philadelphia: Elsevier; 2005. p. 839–52.

    Chapter  Google Scholar 

  3. Michaud M, Dumont M, Selmaoui B, Paquet J, Fantini ML, Montplaisir J. Circadian rhythm of restless legs syndrome: relationship with biological markers. Ann Neurol. 2004;55:372–80.

    Article  CAS  PubMed  Google Scholar 

  4. Hening W, Walters A, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms and treatment) primary care study. Sleep Med. 2004;5:237–46.

    Article  PubMed  Google Scholar 

  5. Winkelmann J, Wetter TC, Collado-Seidel V, Gasser T, Dichgans M, Yassouridis A, Trenkwalder C. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep. 2000;23:597–602.

    Article  CAS  PubMed  Google Scholar 

  6. Whittom S, Dauvilliers Y, Pennestri MH, Vercauteren F, Molinari N, Petit D, Montplaisir J. Age-at-onset in restless legs syndrome: a clinical and polysomnographic study. Sleep Med. 2007;9:54–9.

    Article  CAS  PubMed  Google Scholar 

  7. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J, Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health, International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med. 2003;4:101–19.

    Article  PubMed  Google Scholar 

  8. Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev. 2006;10:153–67.

    Article  PubMed  Google Scholar 

  9. Allen RP, Walters A, Montplaisir J, Hening W, Myers A, Bell TJ, Ferini-Strambi L. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165:1286–92.

    Article  PubMed  Google Scholar 

  10. Budhiraja P, Budhiraja R, Goodwin JL, Allen RP, Newman AB, Koo BB, Quan SF. Incidence of restless legs syndrome and its correlates. J Clin Sleep Med. 2012;8(2):119–24.

    PubMed  PubMed Central  Google Scholar 

  11. Szentkiralyi A, Fendrich K, Hoffmann W, Happe S, Berger K. Incidence of restless legs syndrome in two population-based cohort studies in Germany. Sleep Med. 2011;12(9):815–20.

    Article  PubMed  Google Scholar 

  12. Kagimura T, Nomura T, Kusumi M, Nakashima K, Inoue Y. Prospective survey on the natural course of restless legs syndrome over two years in a closed cohort. Sleep Med. 2011;12(9):821–6.

    Article  PubMed  Google Scholar 

  13. American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien: American Academy of Sleep Medicine; 2014.

    Google Scholar 

  14. Zucconi M, Ferri R, Allen R, Baier PC, Bruni O, Chokroverty S, Ferini-Strambi L, Fulda S, Garcia-Borreguero D, Hening WA, Hirshkowitz M, Högl B, Hornyak M, King M, Montagna P, Parrino L, Plazzi G, Terzano MG, International Restless Legs Syndrome Study Group (IRLSSG). The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Med. 2006;7:175–83.

    Article  PubMed  Google Scholar 

  15. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56:263–5.

    Article  CAS  PubMed  Google Scholar 

  16. Earley CJ, Barker P, Horska A, Allen RP. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med. 2006;7:458–61.

    Article  PubMed  Google Scholar 

  17. Connor JR, Wang XS, Patton SM, Enzies SL, Troncoso JC, Earley CJ, Allen RP. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology. 2004;62:1563–7.

    Article  CAS  PubMed  Google Scholar 

  18. Connor JR, Wang XS, Allen RP, Beard JL, Wiesinger JA, Felt BT, Earley CJ. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain. 2009;132:2403–12.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Rios Romenets S, Dauvilliers Y, Cochen de Cock V, Carlander B, Bayard S, Galatas C, Wolfson C, Postuma RB. Restless legs syndrome outside the blood–brain barrier-exacerbation by domperidone in Parkinson’s disease. Parkinsonism Relat Disord. 2013;19:92–4.

    Article  CAS  PubMed  Google Scholar 

  20. Oertel WH, Trenkwalder C, Zucconi M, Benes H, Borreguero DG, Bassetti C, Partinen M, Ferini-Strambi L, Stiasny-Kolster K. State of the art in restless legs syndrome: practice recommendations for treating restless legs syndrome. Mov Disord. 2007;22 Suppl 18:S466–75.

    Article  PubMed  Google Scholar 

  21. Garcia-Borreguero D, Stillman P, Benes H, Buschmann H, Chaudhuri KR, Gonzalez Rodríguez VM, Högl B, Kohnen R, Monti GC, Stiasny-Kolster K, Trenkwalder C, Williams AM, Zucconi M. Algorithms for the diagnosis and treatment of restless legs syndrome in primary care. BMC Neurol. 2011;11:28.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Stiasny-Kolster K, Kohnen R, Moller JC, Oertel W. Validation of “L-dopa test” for diagnosis of restless legs syndrome. Mov Disord. 2006;21:1333–9.

    Article  PubMed  Google Scholar 

  23. Garcia-Borreguero D, Allen RP, Kohnen R, Högl B, Trenkwalder C, Oertel W, Hening WA, Paulus W, Rye D, Walters A, Winkelmann J, Earley CJ, International Restless Legs Syndrome Study Group. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med. 2007;8:520–30.

    Article  PubMed  Google Scholar 

  24. Vignatelli L, Billiard M, Clarenbach P, Garcia-Borreguero D, Kaynak D, Liesiene V, Trenkwalder C, Montagna P, Task Force EFNS. EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep. Eur J Neurol. 2006;13:1049–65.

    Article  CAS  PubMed  Google Scholar 

  25. Collado-Seidel V, Kazenwadel J, Wetter TC, Kohnen R, Winkelmann J, Selzer R, Oertel WH, Trenkwalder C. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms. Neurology. 1999;52:285–90.

    Article  CAS  PubMed  Google Scholar 

  26. Garcia-Borreguero D, Kohnen R, Hogl B, Ferini-Strambi L, Hadjigeorgiou GM, Hornyak M, de Weerd AW, Happe S, Stiasny-Kolster K, Gschliesser V, Egatz R, Cabrero B, Frauscher B, Trenkwalder C, Hening WA, Allen RP. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levo-dopa in RLS. Sleep Med. 2007;8:455–63.

    Article  PubMed  Google Scholar 

  27. Ferini-Strambi L, Marelli S. Pharmacotherapy for restless legs syndrome. Expert Opin Pharmacother. 2014;15(8):1127–38.

    Article  CAS  PubMed  Google Scholar 

  28. Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin. Neurology. 2002;59:1573–9.

    Article  CAS  PubMed  Google Scholar 

  29. Allen RP, Chen C, Garcia-Borreguero D, Polo O, DuBrava S, Miceli J, Knapp L, Winkelman JW. Comparison of pregabalin with pramipexole for restless legs syndrome. N Engl J Med. 2014;370(7):621–31.

    Article  CAS  PubMed  Google Scholar 

  30. Trenkwalder C, Benes H, Grote L, García-Borreguero D, Högl B, Hopp M, Bosse B, Oksche A, Reimer K, Winkelmann J, Allen RP, Kohnen R, RELOXYN Study Group. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Lancet Neurol. 2013;12:1141–50.

    Article  CAS  PubMed  Google Scholar 

  31. Silber MH, Becker PM, Earley C, Garcia-Borreguero D, Ondo WG, Medical Advisory Board of the Willis-Ekbom Disease Foundation. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. Mayo Clin Proc. 2013;88(9):977–86.

    Article  PubMed  Google Scholar 

  32. Liu R, Moizuddin M, Hung S. Painful legs and moving toes-case report and review of literature. BJMP. 2011;4(3):431–4.

    Google Scholar 

  33. Jabbari B, Molloy FM, Erickson M, Floeter MK. Bilateral painful hand-moving fingers: electrophysiological assessment of the central nervous system oscillator. Mov Disord. 2000;6:1259–63.

    Article  Google Scholar 

  34. Rodriguez RL, Fernandez HH. Sustained benefit of painful legs moving toes syndrome with botulinum toxin type A. J Clin Neurosci. 2013;20(7):1031–2.

    Article  PubMed  Google Scholar 

  35. Beckmann Y1, Gürgör N, Bülbül NG, Seçil Y, Türkmen N. Painful legs and moving toes syndrome: responsive to dopaminergic treatment. Acta Neurol Belg. 2015;115(1):87–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luigi Ferini-Strambi MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Wien

About this chapter

Cite this chapter

Ferini-Strambi, L., Marelli, S., Combi, R. (2017). Restless Legs Syndrome and Painful Legs/Moving Toes. In: Falup-Pecurariu, C., Ferreira, J., Martinez-Martin, P., Chaudhuri, K. (eds) Movement Disorders Curricula. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1628-9_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-1628-9_36

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-1627-2

  • Online ISBN: 978-3-7091-1628-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics